Leishmania major-human macrophage interactions: Cooperation between Mac-1 (CD11b/CD18) and complement receptor type 1 (CD35) in promastigote adhesion

Infection and Immunity

Volumn 64, Issue 6, 1996, Pages 2206-2215

  Rosenthal, Louis A ^a,c   Sutterwala, Fayyaz S ^a   Kehrli, Marcus E ^b   Mosser, David M ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b U S DEPARTMENT OF AGRICULTURE   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR;

ANIMAL CELL; ARTICLE; CATTLE; CELL FREE SYSTEM; CHO CELL; CONTROLLED STUDY; DNA TRANSFECTION; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; LEISHMANIA MAJOR; MACROPHAGE; MONOCYTE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROMASTIGOTE;

EID: 0029948726     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.6.2206-2215.1996     Document Type: Article

References (51)

1. Altieri, D. C., R. Bader, P. M. Mannucci, and T. S. Edgington. 1988. Oligo-specificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen. J. Cell Biol. 107:1893-1900.
2. Altieri, D. C., and T. S. Edgington. 1988. The saturable high affinity association of factor X to ADP-stimulated monocytes defines a novel function of the Mac-1 receptor. J. Biol. Chem. 263:7007-7015.
3. Beller, D. I., T. A. Springer, and R. D. Schreiber. 1982. Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor. J. Exp. Med. 156:1000-1009.
4. Blackwell, J. M., R. A. B. Ezekowitz, M. B. Roberts, J. Y. Channon, R. B. Sim, and S. Gordon. 1985. Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. J. Exp. Med. 162:324-331.
5. Brittingham, A., C. J. Morrison, W. R. McMaster, B. S. McGwire, K. P. Chang, and D. M. Mosser. 1995. The role of the Leishmania surface protease, gp63, in complement fixation, cell adhesion, and resistance to complement-mediated lysis. J. Immunol. 155:3102-3111.
6. Da Silva, R., and D. L. Sacks. 1987. Metacyclogenesis is a major determinant of Leishmania promastigote virulence and attenuation. Infect. Immun. 55: 2802-2806.
7. DaSilva, R. P., F. B. Hall, K. A. Joiner, and D. L. Sacks. 1989. CR1, the C3b receptor, mediates binding of infective Leishmania major promastigotes to human macrophages. J. Immunol. 143:617-622.
8. Diamond, M. S., J. Garcia-Aguilar, J. K. Bickford, A. L. Corbi, and T. A. Springer. 1993. The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J. Cell Biol. 120:1031-1043.
9. Diamond, M. S., and T. A. Springer. 1993. A subpopulalion of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J. Cell Biol. 120:545-556.
10. Diamond, M. S., D. E. Staunton, S. D. Marlin, and T. A. Springer. 1991. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 65:961-971.
11. Fearon, D. T. 1979. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane. Proc. Natl. Acad. Sci. USA 76:5867-5871.
12. Gorman, C., R. Padmanabhan, and B. H. Howard. 1983. High efficiency DNA-mediated transformation of primate cells. Science 221:551-553.
13. Handman, E., and J. W. Goding. 1985. The Leishmania receptor for macrophages is a lipid-containing glycoconjugate. EMBO J. 4:329-336.
14. Harrison, R. A., and P. J. Lachmann. 1980. The physiological breakdown of the third component of human complement. Mol. Immunol. 17:9-20.
15. Hondalus, M. K., M. S. Diamond, L. A. Rosenthal, T. A. Springer, and D. M. Mosser. 1993. The intracellular bacterium Rhodococcus equi requires Mac-1 to bind to mammalian cells. Infect. Immun. 61:2919-2929.
16. Iida, K., and V. Nussenzweig. 1981. Complement receptor is an inhibitor of the complement cascade. J. Exp. Med. 153:1138-1150.
17. Kaufman, Y., E. Tseng, and T. A. Springer. 1991. Cloning of the murine lymphocyte function-associated molecule-1 α-subunit and its expression in COS cells. J. Immunol. 147:369-374.
18. Kehrli, M. E., Jr., F. C. Schmalstieg, D. C. Anderson, M. J. van der Matten, B. J. Hughes, M. R. Ackermann, C. L. Wilhelmsen, G. B. Brown, M. G. Stevens, and C. A. Whetstone. 1990. Molecular definition of the bovine granulopathy syndrome: identification of deficiency of the Mac-1 (CD11b/ CD18) glycoprotein. Am. J. Vet. Res. 51:1826-1836.
19. Kelleher, M., A. Bacic, and E. Handman. 1992. Identification of a macrophage-binding determinant on lipophosphoglycan from Leishmania major promastigotes. Proc. Natl. Acad. Sci. USA 89:6-10.
20. Klickstein, L. B., T. J. Bartow, V. Miletic, L. D. Rabson, J. A. Smith, and D. T. Fearon. 1988. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis. J. Exp. Med. 168:1699-1717.
21. Lambris, J. D., O. Scheiner, T. F. Schulz, J. Alsenz, and M. P. Dierich. 1983. Coupling of C3b to erythrocytes by disulfide bond formation: preparation of EC3b for hemolytic and complement receptor assays. J. Immunol. Methods 65:277-283.
22. Lawyer, P. G., P. M. Ngumbi, C. O. Anjili, S. O. Odongo, Y. B. Mebrahtu, J. I. Githure, D. K. Koech, and C. R. Roberts. 1990. Development of Leishmania major in Phlebotomus duboscqi and Sergentomyia scwetzi (Diptera: Psychodidae). Am. J. Trop. Med. Hyg. 43:31-43.
23. Medof, M. E., K. Iida, C. Mold, and V. Nussenzweig. 1982. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. J. Exp. Med. 156:1739-1754.
24. Micklem, K. J., and R. B. Sim. 1985. Isolation of complement-fragment-iC3b-binding proteins by affinity chromatography. The identification of p150,95 as an iC3b-binding protein. Biochem. J. 231:233-236.
25. Miller, L. J., R. Schwarting, and T. A. Springer. 1986. Regulated expression of the Mac-1, LFA-1, p150-95 glycoprotein family during leukocyte differentiation. J. Immunol. 137:2891-2900.
26. Mosser, D. M., and P. J. Edelson. 1984. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages. J. Immunol. 132:1501-1505.
27. Mosser, D. M., and P. J. Edelson. 1985. The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes. J. Immunol. 135:2785-2789.
28. Mosser, D. M., and P. J. Edelson. 1987. The third component of complement (C3) is responsible for the intracellular survival of Leishmania major. Nature (London) 327:329-331.
29. Mosser, D. M., and E. Handman. 1992. Treatment of murine macrophages with interferon-γ inhibits their ability to bind leishmania promastigotes. J. Leukocyte Biol. 52:369-376.
30. Mosser, D. M., and L. A. Rosenthal. 1993. Leishmania-macrophage interactions: multiple receptors, multiple ligands and diverse cellular responses. Semin. Cell Biol. 4:315-322.
31. Mosser, D. M., T. A. Springer, and M. S. Diamond. 1992. Leishmania promastigotes require opsonic complement to bind to the human leukocyte integrin Mac-1 (CD11b/CD18). J. Cell Biol. 116:511-520.
32. Mosser, D. M., H. Vlassara, P. J. Edelson, and A. Cerami. 1987. Leishmania promastigotes are recognized by the macrophage receptor for advanced glycosylation endproducts. J. Exp. Med. 165:140-145.
33. Myones, B. L., J. G. Daizell, N. Hogg, and G. D. Ross. 1988. Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3. J. Clin. Invest. 82:640-651.
34. Noel, G. J., D. M. Mosser, and P. J. Edelson. 1990. Role of complement in mouse macrophage binding of Haemophilus influenzae type b. J. Clin. Invest. 85:208-218.
35. O'Shea, J. J., E. J. Brown, B. E. Seligmann, J. A. Melcalf, M. M. Frank, and J. I. Gallin. 1985. Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. J. Immunol. 134:2580-2587.
36. Ross, G. D., J. D. Lambris, J. A, Cain, and S. L. Newman. 1982. Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H is CR1 cofactor activity. J. Immunol. 129:2051-2060.
37. Sacks, D. L. 1992. The structure and function of the surface lipophosphoglycan on different developmental stages of Leishmania promastigotes. Infect. Agents Dis. 1:200-206.
38. Sacks, D. L., S. Hieny, and A. Sher. 1985. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes. J. Immunol. 135: 564-569.
39. Sacks, D. L., and P. V. Perkins. 1984. Identification of an infective stage of Leishmania promastigotes. Science 223:1417-1419.
40. Shuster, D. E., M. E. Kehrli, Jr., M. H. Ackermann, and R. O. Gilbert. 1992. Identification and prevalence of a genetic defect that causes leukocyte adhesion deficiency in Holstein cattle. Proc. Natl. Acad. Sci. USA 89:9225-9229.
41. Sim, R. B., A. J. Day, B. E. Moffatt, and M. Fontaine. 1993. Complement factor I and cofactors in control of complement system convertase enzymes. Methods Enzymol. 223:13-35.
42. Smith, C. W., S. D. Marlin, R. Rothlein, C. Toman, and D. C. Anderson. 1989. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J. Clin. Invest. 83:2008-2017.
43. Soteriadou, K. P., M. S. Remoundos, M. C. Katsikas, A. K. Tzinia, V. Tsikaris, C. Sakarellos, and S. J. Tzartos. 1992. The Ser-Arg-Tyr-Asp region of the major surface glycoprotein of Leishmania mimics the Arg-Gly-Asp-Ser cell attachment region of fibronectin. J. Biol. Chem. 267:13980-13985.
44. Sutterwala, F. S., L. A. Rosenthal, and D. M. Mosser. Cooperation between CR1 (CD35) and CR3 (CD11b/CD18) in the binding of complement-opsonized particles. J. Leukocyte Biol., in press.
45. Talamas-Rohana, P., S. D. Wright, M. R. Lennartz, and D. G. Russell. 1990. Lipophosphoglycan from Leishmania mexicana promastigotes binds to members of the CR3, p150,95 and LFA-1 family of leukocyte integrins. J. Immunol. 144:4817-4824.
46. Van Strijp, J. A. G., D. G. Russell, E. Toumanen, E. J. Brown, and S. D. Wright. 1993. Ligand specificity of purified complement receptor type three (CD11b/CD18, αmβ2, Mac-1). J. Immunol. 151:3324-3336.
47. Wilson, M. E., and R. D. Pearson. 1986. Evidence that Leishmania donovani utilizes a mannose receptor on human mononuclear phagocytes to establish intracellular parasitism. J. Immunol. 136:4681-4688.
48. Wright, S. D., and M. T. C. Jong. 1986. Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide. J. Exp. Med. 164:1876-1888.
49. Wright, S. D., P. E. Rao, W. C. V. Voorhis, L. S. Craigmyle, K. Iida, M. A. Talle, E. F. Westberg, G. Goldstein, and S. C. Silverstein. 1983. Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies. Proc. Natl. Acad. Sci. USA 80:5699-5703.
50. Wright, S. D., J. I. Weitz, A. J. Huang, S. M. Leyin, S. C. Silverstein, and J. D. Loike. 1988. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. Proc. Natl. Acad. Sci. USA 85:7734-7738.
51. Wyler, D. J., J. P. Sypek, and J. A. McDonald. 1985. In vitro parasite-monocyte interactions in human leishmaniasis: possible role of fibronectin in parasite attachment. Infect. Immun. 49:305-311.